Redrawing Cities with Children and Adolescents: Development of a Framework and Opportunity Index for Wellbeing-The REDibuja Study Protocol

Int J Environ Res Public Health. 2022 Apr 27;19(9):5312. doi: 10.3390/ijerph19095312.

Abstract

Global changes require urgent integration of health and wellbeing into all urban policies. Complex social and environmental factors define wellbeing outcomes and inequities present in cities. Additionally, political decisions are seldom thought and developed considering the needs and participation of children and adolescents. The REDibuja study aims to develop a multidimensional framework of wellbeing for children and adolescents and to validate an index of opportunities for better wellbeing for children and adolescents in the urban context of Temuco, Chile. This child-centered and cross-sectional study will involve mixed methodologies throughout the implementation of five work packages for two years (2022-2023): (1) development of a conceptual framework for child and adolescent wellbeing, (2) integration of available and public data, (3) studies in the local context, (4) data integration using geographic information systems, and (5) validation of the wellbeing opportunity index for children and adolescents. REDibuja will implement methodologies that until now are little used to facilitate political decisions in our regional context. This process and results could be transferred for assessment and decision-making in Latin America and low- and middle-income countries in other regions.

Keywords: health in all policies; inequity; quality of life; urban health; wellbeing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Chile
  • Cities
  • Cross-Sectional Studies*
  • Humans
  • Latin America

Grants and funding

This work was funded by the Ministry of Education Chile and the Universidad de La Frontera through the Innovation in Higher Education Program (INES—FRO19-101). Additionally, F.R.M. is funded by FONDECYT 11190961, J.C.-O. is funded by FONDECYT 1210616, and T.B.-C. by FONIS SA18I0045.